Skip to content
healthcare.dev
Get a free key

ASPRUZYO SPRINKLE

NDC 47335-625, Ranolazine, granule, from SUN PHARMACEUTICAL INDUSTRIES, INC..

Product NDC
47335-625
Status
Listed
Labeler
SUN PHARMACEUTICAL INDUSTRIES, INC.
Dosage form
GRANULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216018
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/47335-625 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RANOLAZINE1000 mg/1

Pharmacologic classes

Anti-anginal [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
47335-625-11473350625111 GRANULE in 1 PACKET (47335-625-11)
47335-625-304733506253030 GRANULE in 1 CARTON (47335-625-30)
47335-625-604733506256060 GRANULE in 1 CARTON (47335-625-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/dd9f81e4-50da-4551-aed5-559d304df42e

Use it

Look up 47335-625 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/47335-625 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 47335-625. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.